scholarly article | Q13442814 |
P356 | DOI | 10.1097/00007890-200211150-00014 |
P698 | PubMed publication ID | 12451266 |
P50 | author | Friedrich Port | Q95277507 |
P2093 | author name string | Jennifer L Bragg-Gresham | |
Brenda W Gillespie | |||
Robert A Wolfe | |||
Eric W Young | |||
Francis L Delmonico | |||
Robert M Merion | |||
Robert A Metzger | |||
James J Wynn | |||
Dawn M Dykstra | |||
Philip J Held | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1281-1286 | |
P577 | publication date | 2002-11-01 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. | |
P478 | volume | 74 |
Q91732947 | A Novel Technique of Dual Kidney Transplantation (DKT) From Adult Donors |
Q40986868 | A Risk Index for Living Donor Kidney Transplantation |
Q52668475 | A novel rodent model of severe renal ischemia reperfusion injury. |
Q31065576 | A semiparametric additive rates model for recurrent event data |
Q37852808 | Accepting kidneys from older living donors: impact on transplant recipient outcomes. |
Q46075978 | Acute kidney injury before organ procurement is associated with worse long-term kidney graft outcome |
Q33747421 | Advances in the Knowledge about Kidney Decellularization and Repopulation |
Q80363857 | Age and the allocation of organs for transplantation: a case study |
Q50688492 | Aging has small effects on initial ischemic acute kidney injury development despite changing intrarenal immunologic micromilieu in mice. |
Q54247790 | An Examination of the Application of the Kidney Donor Risk Index in British Columbia. |
Q59802813 | An improved rapid sampling microdialysis system for human and porcine organ monitoring in a hospital setting |
Q38267202 | An update on ABO-incompatible kidney transplantation |
Q84693888 | Analysis of Four Scoring Systems and Monocentric Experience to Optimize Criteria for Marginal Kidney Transplantation |
Q90704633 | Analysis of Risk Factors for Allograft Outcome Comparing 2 Kidneys From the Same Donor in Separate Recipients |
Q48281509 | Analysis of local versus imported expanded criteria donor kidneys: A single-center experience with 497 ECD kidney transplants |
Q34373374 | Assessment of deceased donor kidneys using a donor scoring system. |
Q37832966 | Assessment of kidney organ quality and prediction of outcome at time of transplantation |
Q58604623 | Association of Kidney Donor Risk Index with the Outcome after Kidney Transplantation in the Eurotransplant Senior Program |
Q99726581 | Association of Physical Function and Survival in Older-Adult Renal Transplant Recipients |
Q48350293 | Baseline donor chronic renal injury confers the same transplant survival disadvantage for DCD and DBD kidneys. |
Q30837288 | Big data in organ transplantation: registries and administrative claims |
Q48847948 | Brain death after severe traumatic brain injury: the role of systemic secondary brain insults. |
Q44401254 | Cardiovascular risk in recipients with kidney transplants from expanded criteria donors |
Q37801909 | Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits. |
Q53355016 | Cold ischemic time is critical in outcomes of expanded criteria donor renal transplantation. |
Q40962990 | Combined predictive value of the expanded donor criteria for long-term graft survival of kidneys from donors after cardiac death: A single-center experience over three decades |
Q43429455 | Comparing molecular assessment of implantation biopsies with histologic and demographic risk assessment |
Q86254882 | Comparison of cadaveric kidney transplantation from in-center and external center donors |
Q38693363 | Comparison of survival outcomes between Expanded Criteria Donor and Standard Criteria Donor kidney transplant recipients: a systematic review and meta-analysis. |
Q40378893 | Comparisons of the performance of different statistical tests for time-to-event analysis with confounding factors: practical illustrations in kidney transplantation |
Q43663713 | Complications of kidney transplantation with grafts from expanded criteria donors |
Q36752025 | Consideration of donor age and human leukocyte antigen matching in the setting of multiple potential living kidney donors |
Q45253164 | Correlation between dual kidney biopsy in expanded-criteria donors and transplant survival |
Q37360103 | Crossmatch testing in kidney transplantation: patterns of practice and associations with rejection and graft survival. |
Q46465681 | Current status of kidney and pancreas transplantation in the United States, 1994-2003. |
Q50711738 | Cyclodextrin curcumin formulation improves outcome in a preclinical pig model of marginal kidney transplantation. |
Q35558186 | Deceased donor neutrophil gelatinase-associated lipocalin and delayed graft function after kidney transplantation: a prospective study |
Q43155500 | Deceased donor organ transplantation with expanded criteria donors: a single-center experience from India |
Q41970837 | Deceased donor renal transplantation at army hospital research and referral: Our experience |
Q37110318 | Deceased organ donor characteristics and clinical interventions associated with organ yield |
Q46403947 | Deceased-donor kidney transplantation: improvement in long-term survival |
Q40731483 | Decision Making by Young Transplant Surgeons Regarding Expanded-Criteria Donors With Acute Kidney Injury or Allocation Failure |
Q39748280 | Delayed Graft Function in Kidney Transplantation: Risk Factors and Impact on Early Graft Function. |
Q46105892 | Delayed graft function has an equally bad impact on deceased donor renal graft survival in both standard criteria donors and expanded criteria donors. |
Q89695408 | Delayed graft function is correlated with graft loss in recipients of expanded-criteria rather than standard-criteria donor kidneys: a retrospective, multicenter, observation cohort study |
Q47245721 | Determinants of discard of expanded criteria donor kidneys: impact of biopsy and machine perfusion. |
Q50167105 | Developing organ offer and acceptance measures: when 'good' organs are turned down |
Q35903771 | Development of organ-specific donor risk indices. |
Q38639618 | Do elderly recipients really benefit from kidney transplantation? |
Q47836044 | Does Kidney Donor Risk Index implementation lead to the transplantation of more and higher-quality donor kidneys? |
Q45641517 | Does expanded criteria donor status modify the outcomes of kidney transplantation from donors after cardiac death? |
Q38221991 | Does machine perfusion decrease ischemia reperfusion injury? |
Q48585615 | Donation and Transplantation of Kidneys Harvested From Deceased Donors Over the Age of 60 Years in the Upper Silesia Region. |
Q37346590 | Donor Characteristics of Pancreas Transplantation in Australia and New Zealand: A Cohort Study 1984-2014 |
Q37952779 | Donor age-specific injury and immune responses |
Q45244535 | Donor cause of brain death in renal transplantation: a predictive factor for graft function? |
Q38486023 | Donor characteristics associated with reduced survival of transplanted kidney grafts in Korea. |
Q46401695 | Donor kidney biopsies: pathology matters, and so does the pathologist |
Q53552403 | Donor kidney volume and outcomes following live donor kidney transplantation. |
Q30409680 | Donor risk index predicts graft failure reliably but not post-transplant infections |
Q104568813 | Donor-Recipient Matching to Optimize the Utility of High Kidney Donor Profile Index Kidneys |
Q39826096 | Dual Kidney Transplantation: Evaluation of Recipient Selection Criteria at Niguarda Hospital |
Q85281109 | Dual kidney transplantation: a single-center experience |
Q38702286 | Dual kidney transplants from adult marginal donors successfully expand the limited deceased donor organ pool |
Q46481364 | ECD kidney transplantation outcomes are improved when matching donors to recipients using a novel creatinine clearance match ratio (CCMR). |
Q55129426 | Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation. |
Q88070846 | Early and Long-Term Outcomes of Kidney Grafts Procured From Multiple-Organ Donors and Kidney-Only Donors |
Q50955894 | Early graft loss after kidney transplantation: risk factors and consequences. |
Q40847329 | Early renal function recovery and long-term graft survival in kidney transplantation |
Q38402107 | Effect of Donor-Recipient Age Match in Expanded Criteria Deceased Donor Kidney Transplantation |
Q46439163 | Effect of donor selection on the early outcome of heart transplant recipients |
Q42681551 | Effect on graft and patient survival between shipped and locally transplanted well-matched cadaveric renal allografts in Australia over a 10-year period |
Q35684478 | Efficient utilization of the expanded criteria donor (ECD) deceased donor kidney pool: an analysis of the effect of labeling |
Q38698950 | Elevated HbA1c in donor organs from patients without a diagnosis of diabetes portends worse liver allograft survival. |
Q34778701 | Enhancing the Expanded Criteria Donor Policy as an Intervention to Improve Kidney Allocation: Is It Actually a ‘Net-Zero’ Model? |
Q91740932 | Epidemiology, Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study |
Q35998855 | Estimating treatment effects on the marginal recurrent event mean in the presence of a terminating event |
Q91097544 | Ethical Issues in the Use of Suboptimal Kidneys for Transplants: An Italian Point of View |
Q33868422 | Ethical tensions in solid organ transplantation: the price of success |
Q49338773 | Evaluation of Frozen and Paraffin Sections Using the Maryland Aggregate Pathology Index Score in Donor Kidney Biopsy Specimens of a Brazilian Cohort |
Q92413513 | Expanded Criteria Donor Kidneys With Kidney Donor Profile Index ≤ 85%: Are We Doing Enough to Counsel Our Patients? |
Q58993955 | Expanded Criteria Donors in Kidney Transplantation: The Role of Older Donors in a Setting of Older Recipients |
Q46438352 | Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center |
Q41086666 | Expanded criteria donor kidneys for retransplantation United Network for Organ Sharing update: proceed with caution |
Q82137830 | Expanded criteria donors for kidney transplantation |
Q35106631 | Expanded criteria donors for kidney transplantation. |
Q28086850 | Expanding the pool of kidney donors: use of kidneys with acute renal dysfunction |
Q87542509 | Expanding the use of expanded criteria donors in kidney transplantation |
Q35180107 | Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool |
Q87491661 | Factors having effect on graft survival in cadaveric renal transplantation |
Q26825480 | Factors influencing long-term outcome after kidney transplantation |
Q42418248 | First Robotic-Assisted Dual Kidney Transplant: Surgical Technique and Report of a Case With 24-month Follow-up |
Q35735121 | Flexible estimation of differences in treatment-specific recurrent event means in the presence of a terminating event |
Q36288875 | Geographic Variation in Cold Ischemia Time: Kidney vs. Liver Transplantation in the United States, 2003-2011. |
Q37330552 | H-Y incompatibility predicts short-term outcomes for kidney transplant recipients |
Q35094769 | Hepatitis C and kidney transplantation |
Q90117063 | Histological and clinical evaluation of marginal donor kidneys before transplantation: Which is best? |
Q48283824 | Histopathological evaluation of pretransplant donor biopsies in expanded criteria donors with high kidney donor profile index: a retrospective observational cohort study. |
Q46614187 | How to achieve more accurate comparisons in organ donation activity: time to effectiveness indicators |
Q46354717 | Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation |
Q91739017 | Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial |
Q90455081 | Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial |
Q35067649 | Hypothermic machine perfusion reduces delayed graft function and improves one-year graft survival of kidneys from expanded criteria donors: a meta-analysis |
Q93044166 | Impact of Donor Age on the Outcomes of Kidney Transplantation From Deceased Donors With Histologic Acute Kidney Injury |
Q96761988 | Impact of Donor-Recipient Age Difference on Graft Function and Survival After Deceased Donor Kidney Transplantation |
Q37649682 | Impact of a quality improvement project on deceased organ donor management |
Q38063943 | Impact of donor age on long-term outcomes after delayed graft function: 10-year follow-up. |
Q37450228 | Impact of donor age on renal allograft function and survival |
Q48378508 | Impact of expanded criteria donors on outcomes of recipients after kidney transplantation |
Q43155477 | Impact of recipient and donor nonimmunologic factors on the outcome of deceased donor kidney transplantation. |
Q43814291 | Impact of static cold storage VS hypothermic machine preservation on ischemic kidney graft: inflammatory cytokines and adhesion molecules as markers of ischemia/reperfusion tissue damage. Our preliminary results. |
Q35758307 | Improving liver allocation: MELD and PELD. |
Q44843608 | Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant |
Q37360572 | Increased resistin in brain dead organ donors is associated with delayed graft function after kidney transplantation. |
Q40573694 | Increased risk of graft failure and mortality in Dutch recipients receiving an expanded criteria donor kidney transplant |
Q37826221 | Increasing organ donation and transplantation: the U.S. experience over the past decade |
Q37997296 | Increasing the pool of deceased donor organs for kidney transplantation |
Q91301250 | Induction Therapy With ATG Compared With Anti-IL2 Basiliximab in Low-Immunologic Risk Kidney Transplant Recipients |
Q42157160 | Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study |
Q36204502 | Influence of Deceased Donor and Pretransplant Recipient Parameters on Early Overall Kidney Graft-Survival in Germany |
Q41499418 | Influence of Donor's Renal Function on the Outcome of Living Kidney Transplantation: 10-Year Follow-up. |
Q84962682 | Influence of donor age on graft survival |
Q48571300 | Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality? |
Q38541489 | Intraoperative biomarkers in renal transplantation. |
Q84757363 | Is it safe to use a kidney from an expanded criteria donor? |
Q38256678 | Is the Kidney Donor Risk Index a step forward in the assessment of deceased donor kidney quality? |
Q95658169 | Is the Living Donor Kidney Profile Index Valuable in Japanese Patients? |
Q90704644 | Kidney Transplantation Using Expanded-Criteria Deceased Donors: A Comparison With Ideal Deceased Donors and Non-Expanded-Criteria Deceased Donors |
Q38668179 | Kidney and liver transplantation in the elderly |
Q38382844 | Kidney donation after circulatory death (DCD): state of the art. |
Q38158572 | Kidney preservation: review of present and future perspective. |
Q33767453 | Kidney transplantation in the elderly |
Q38658621 | Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. |
Q50177329 | Kidneys With Small Renal Cell Carcinoma Used in Transplantation After Ex Vivo Partial Nephrectomy |
Q33979361 | Kidneys from donors after cardiac death provide survival benefit |
Q35135224 | Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. |
Q35917423 | Living donor age and kidney allograft half-life: implications for living donor paired exchange programs |
Q51807890 | Living donor kidney transplantation from the elderly donor. |
Q88375256 | Living-Donor Kidney Transplantation: Donor-Recipient Function Correlation |
Q48156061 | Local Expansion of Donation After Circulatory Death Kidney Transplant Activity Improves Waitlisted Outcomes and Addresses Inequities of Access to Transplantation. |
Q35907637 | Long term outcomes of transplantation using kidneys from expanded criteria donors: prospective, population based cohort study. |
Q91608619 | Long-Term Function of Kidneys From an Acute Renal Failure Donor on Continuous Venovenous Hemofiltration: A Case Report |
Q39808031 | Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study |
Q50688940 | Long-Term Outcomes of Kidney Transplantation From Expanded-Criteria Deceased Donors: A Single-Center Experience. |
Q57297934 | Long-term effects of delayed graft function duration on function and survival of deceased donor kidney transplants |
Q42264108 | Long-term exposure to belatacept in recipients of extended criteria donor kidneys. |
Q40471639 | Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil. |
Q38440171 | Long-term outcomes of kidney transplantation from expanded criteria deceased donors at a single center: comparison with standard criteria deceased donors |
Q44845631 | Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy |
Q92386979 | Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation |
Q59049763 | Managing End-Stage Renal Disease in Older Patients: A Single Centre Experience with Renal Transplantation in the Elderly |
Q38533032 | Marginal Donors in Renal Transplantation |
Q37218148 | Matching graft to recipient by predicted survival: can this be an acceptable strategy to improve utilization of deceased donor kidneys? |
Q44926269 | Middle and long-term outcomes of dual kidney transplant: a multicenter experience |
Q91741418 | Molecular Fingerprints of Borderline Changes in Kidney Allografts Are Influenced by Donor Category |
Q36432878 | Mortality among Younger and Older Recipients of Kidney Transplants from Expanded Criteria Donors Compared with Standard Criteria Donors |
Q54130682 | Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. |
Q36823407 | National outcomes of kidney transplantation from deceased diabetic donors |
Q38780227 | New classification of donation after circulatory death donors definitions and terminology |
Q38477983 | New strategies for evaluating the quality of kidney grafts from elderly donors |
Q24188281 | Normothermic and hypothermic machine perfusion preservation versus static cold storage for deceased donor kidney transplantation |
Q39108113 | Nuclear Magnetic Resonance Strategies for Metabolic Analysis |
Q51643959 | Old donors for kidney transplantation: how old? |
Q93063025 | Older Donation After Circulatory Death Kidneys for Older Recipients: A Single-Center Experience |
Q36250842 | Older living donors provide excellent quality kidneys: a single center experience (older living donors). |
Q42615792 | Opportunities and challenges of expanded criteria organs in liver and kidney transplantation as a response to organ shortage. |
Q84969530 | Optimization of expanded donors using dual kidney transplantation: case-control study |
Q38632080 | Optimized donor management and organ preservation before kidney transplantation |
Q35544050 | Optimizing cadaveric organ procurement: the catalan and Spanish experience. |
Q30456952 | Optimizing recovery, utilization and transplantation outcomes for kidneys from small, ≤20 kg, pediatric donors |
Q50798178 | Optimizing utilization of kidneys from deceased donors over 60 years: five-year outcomes after implementation of a combined clinical and histological allocation algorithm. |
Q38241146 | Organ transplantation from donors (cadaveric or living) with a history of malignancy: review of the literature |
Q47246812 | Outcome of expanded criteria donor kidneys that were transplanted at other Eurotransplant centers after being rejected by our institution. |
Q44382003 | Outcomes in renal transplantation with expanded-criteria donors |
Q45161641 | Outcomes of expanded-criteria deceased donor kidney transplantation in a single center |
Q43210215 | Outcomes of transplanting deceased-donor kidneys between elderly donors and recipients. |
Q50159815 | Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors. |
Q35204736 | Patient selection and volume in the era surrounding implementation of Medicare conditions of participation for transplant programs |
Q36822786 | Pre-transplant Evaluation of Donor Urinary Biomarkers can Predict Reduced Graft Function After Deceased Donor Kidney Transplantation |
Q43240407 | Prediction of delayed graft function using different scoring algorithms: A single-center experience. |
Q85417536 | Prediction of kidney transplant outcome by donor quality scoring systems: expanded criteria donor and deceased donor score |
Q50123132 | Predictors of liver donation without kidney recovery in a cohort of expanded criteria donors: identifying opportunities to improve expanded criteria donor kidney utilization |
Q37621573 | Preimplant histologic acute tubular necrosis and allograft outcomes |
Q33800782 | Preoperative fasting protects against renal ischemia-reperfusion injury in aged and overweight mice. |
Q92470483 | Pretransplant Biopsy of Marginal Kidneys: Is It Necessary? |
Q43595717 | Primary nonfunction (PNF) in the MELD Era: An SRTR database analysis |
Q49188563 | Proceedings From the Symposium on Kidney Disease in Older People: Royal Society of Medicine, London, January 19, 2017. |
Q37407623 | Proportional hazards regression in the presence of missing study eligibility information |
Q37359028 | Racial and socioeconomic disparities in the allocation of expanded criteria donor kidneys |
Q50164445 | Rates of false flagging due to statistical artifact in CMS evaluations of transplant programs: results of a stochastic simulation |
Q90747451 | Recipient Outcomes From Nondirected Live Kidney Donors: A UK-based Cohort Study |
Q94489339 | Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19) |
Q47246992 | Reconditioning by end-ischemic hypothermic in-house machine perfusion: A promising strategy to improve outcome in expanded criteria donors kidney transplantation. |
Q57653170 | Recovery and Utilization of Deceased Donor Kidneys from Small Pediatric Donors |
Q42915281 | Redefining expanded criteria donor kidneys in the developing world |
Q30427250 | Reduced expression of inflammatory genes in deceased donor kidneys undergoing pulsatile pump preservation |
Q33832332 | Regulated payments for living kidney donation: an empirical assessment of the ethical concerns |
Q90595524 | Relationship Between Individual Components of the Extended-Criteria Donor Definition and the First Post-transplant Kidney Graft Resistance Index, Measured by Doppler Sonography |
Q64917047 | Renal allograft survival rates in kidneys initially declined for paediatric transplantation. |
Q36938413 | Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview |
Q36895544 | Renal transplantation in high-risk patients |
Q79804710 | Renal transplantation in the elderly |
Q92709843 | Renal transplantation in the elderly: Outcomes and recommendations |
Q44894310 | Renal transplantation with donors older than 70 years: does age matter? |
Q26751461 | Renal transplantation with expanded criteria donors: Which is the optimal immunosuppression? |
Q46045939 | Renal transplantation with expanded criteria donors: the experience of one Portuguese center. |
Q58792849 | Renal transplants from older deceased donors: Is pre-implantation biopsy useful? A monocentric observational clinical study |
Q40548585 | Results of Expanded-Criteria Donor Kidneys: A Single-Center Experience in Hungary |
Q42795582 | Results of Kidney Transplantation from High–Terminal Creatinine Donors and the Role of Time-Zero Biopsy |
Q90595520 | Results of Transplantation of Kidneys Procured From Donors After Brain Death Aged 60 Years and Older |
Q46890903 | Retrospective follow-up of transplantation of kidneys from 'marginal' donors |
Q42085655 | Risk Balancing of Cold Ischemic Time against Night Shift Surgery Possibly Reduces Rates of Reoperation and Perioperative Graft Loss |
Q43241192 | Risk factors associated with graft loss and patient survival after kidney transplantation. |
Q42616995 | Risk factors for urinary complications after renal transplantation. |
Q97073352 | Robotic assisted dual kidney transplantation with monolateral iliac vessels |
Q79438936 | Selective use of expanded criteria donors for renal transplantation with good results |
Q34005432 | Serum neutrophil gelatinase-associated lipocalin and recovery of kidney graft function after transplantation |
Q79965131 | Shared decision making in deceased-donor transplantation |
Q47420687 | Single centre experience of hypothermic machine perfusion of kidneys from extended criteria deceased heart-beating donors: a comparative study |
Q84410041 | Single transplanted kidneys from a 90-year-old deceased donor perform acceptably at 1 year |
Q44402537 | Sirolimus Prolongs Recovery from Delayed Graft Function After Cadaveric Renal Transplantation |
Q37149440 | Sirolimus use in recipients of expanded criteria donor kidneys |
Q49168337 | Solid organ donation in a child after extracorporeal membrane oxygenation, orthotopic heart transplantation, and ventricular assist device support. |
Q38238522 | Spanish consensus document for acceptance and rejection of kidneys from expanded criteria donors |
Q33787197 | Spanish experience as a leading country: what kind of measures were taken? |
Q39078178 | Strategies for an Expanded Use of Kidneys From Elderly Donors. |
Q48426129 | Successful kidney transplantation from a cadaveric donor unsuitable for other centers due to acute renal failure: a case report |
Q46778442 | Successful use of kidneys from deceased donors with acute renal failure |
Q54962726 | Suggestions on how to make suboptimal kidney transplantation an ethically viable option. |
Q34765151 | Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes |
Q39203012 | Temporal Changes in Deceased Kidney Donor Characteristics in Australia |
Q36725232 | The Canadian experience using the expanded criteria donor classification for allocating deceased donor kidneys for transplantation |
Q48371293 | The Impact of Anastomosis Time During Kidney Transplantation on Graft Loss: A Eurotransplant Cohort Study. |
Q37723319 | The Need for New Donor Stratification to Predict Graft Survival in Deceased Donor Kidney Transplantation |
Q57014398 | The Transcriptome of the Implant Biopsy Identifies Donor Kidneys at Increased Risk of Delayed Graft Function |
Q36249069 | The aging kidney: a review--part II. |
Q38010737 | The contribution of donor quality to differential graft survival in African American and Caucasian renal transplant recipients. |
Q48033174 | The duration of asystolic ischemia determines the risk of graft failure after circulatory-dead donor kidney transplantation: A Eurotransplant cohort study. |
Q50180083 | The economic impact of addressing the organ shortage with clinically high-risk allografts. |
Q40410816 | The effect of anastomosis time on outcome in recipients of kidneys donated after brain death: a cohort study |
Q46148143 | The expanded criteria donor policy: an evaluation of program objectives and indirect ramifications |
Q41626807 | The faster the better: anastomosis time influences patient survival after deceased donor kidney transplantation |
Q44585417 | The impact of deceased donor kidney risk significantly varies by recipient characteristics |
Q64086710 | The relation between zero-time pretransplant deceased donor renal biopsy and kidney transplant survival |
Q73546961 | The report of a national conference on the wait list for kidney transplantation |
Q54524837 | The reproducibility and predictive value on outcome of renal biopsies from expanded criteria donors. |
Q89029584 | Thymoglobulin Versus Basiliximab Induction Therapy in Low-Risk Kidney Transplant Recipients: A Single-Center Experience |
Q90449919 | Tissue conservation for transplantation |
Q92614119 | To discard or not to discard: transplantation and the art of scoring |
Q45073155 | Transplant center quality assessment using a continuously updatable, risk-adjusted technique (CUSUM). |
Q53059916 | Transplantation of Kidneys From Donors With Acute Kidney Injury: Friend or Foe? |
Q89820626 | Transplantation of Marginal Organs: Immunological Aspects and Therapeutic Perspectives in Kidney Transplantation |
Q84307713 | Transplantation: Pump it up: conserving a precious resource? |
Q91184915 | Trends and outcomes in dual kidney transplantation- A narrative review |
Q37527979 | Trends in Usage and Outcomes for Expanded Criteria Donor Kidney Transplantation in the United States Characterized by Kidney Donor Profile Index. |
Q34014709 | Trends in deceased organ donation and utilization in Korea: 2000-2009. |
Q48325686 | Ureteric complications in recipients of kidneys from donation after circulatory death donors |
Q42220278 | Urinary biomarkers of acute kidney injury in deceased organ donors--kidney injury molecule-1 as an adjunct to predicting outcome |
Q40964596 | Urinary biomarkers of chronic allograft nephropathy. |
Q85068710 | Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation |
Q43982072 | Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors. |
Q92377644 | Validation of the Kidney Donor Profile Index (KDPI) to assess a deceased donor's kidneys' outcome in a European cohort |
Q44231262 | Validation of the Maryland Aggregate Pathology Index (MAPI), a pre-implantation scoring system that predicts graft outcome |
Q36298581 | Variables during care of adult donors that can influence outcomes of kidney transplantation |
Q43284034 | Very low-grade proteinuria at 3 months posttransplantation is an earlier marker of graft survival |
Q40622573 | Wedge Versus Core Biopsy at Time Zero: Which Provides Better Predictive Value for Delayed Graft Function With the Remuzzi Histological Scoring System? |
Q35089582 | rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial. |
Search more.